T1	Participants 744 848	53 patients in the experimental arm and 60 in the control arm who reported pain and fatigue at baseline.
T2	Participants 145 351	patients undergoing an initial course of chemotherapy who report pain and fatigue at baseline and who are receiving conventional care alone with those receiving conventional care plus a nursing intervention
